Potential FDA Leadership Change

Marty McCary is emerging as a leading candidate for the new FDA commissioner position, indicating a potential shift in leadership within the agency. Known for his pragmatic approach, McCary has garnered attention for both defending and critiquing policies, particularly around COVID-19 vaccines. His relationship with the current FDA leadership raises questions about future collaboration if he is appointed. This potential appointment could signify a transformation in the FDA's approach to drug approvals and public health initiatives.